Skip to main content
S&P 5007,811.54+0.59%DOW51,654.95+0.83%NASDAQ27,366.17+0.64%BTC$82,516.00+0.84%ETH$2,488.45+0.36%GOLD$4,220.30+1.52%OIL$91.66+0.19%
Smart Investors Daily
SID Premium
FM

NYSE · FMS

Fresenius Medical Care AG & Co. KGaA

Healthcare · Medical - Care Facilities

$21.06

Up+$0.18 (+0.86%)

Updated Oct 10, 2026, 11:09 PM

SID Score

4.9/10

Composite research score

Smart Money

58/100

Neutral

Market cap
13.69B
P/E ratio
17.8
Dividend yield
3.87%
52-week range
$20.02 – $27.64
Volume
1.01M
Avg. volume
415.67K

Price performance · FMS

FMS price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 9, 2026

FMS closed at $21.06 after 21 trading sessions, down 5.77% for the selected period.

Last close
$21.06
Period change
-5.77%
Period low
$20.69
Period high
$22.97
Daily close
View OHLC price history
FMS OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 9, 2026$21.07$21.24$20.905$21.061.01M
Oct 8, 2026$20.28$20.89$20.23$20.881.47M
Oct 7, 2026$22.50$22.665$20.50$20.693.24M
Oct 6, 2026$22.63$22.645$22.415$22.42652.47K
Oct 5, 2026$22.42$22.68$22.34$22.65567.52K
Oct 2, 2026$22.14$22.29$22.09$22.25478.55K
Oct 1, 2026$22.39$22.42$22.1701$22.26537.24K
Sep 30, 2026$22.44$22.585$22.355$22.381.07M
Sep 29, 2026$22.44$22.52$22.05$22.271.38M
Sep 28, 2026$22.91$23.08$22.88$22.95498.7K
Sep 25, 2026$22.45$22.71$22.365$22.69532.84K
Sep 24, 2026$22.19$22.435$22.19$22.351.14M
Sep 23, 2026$22.43$22.635$22.405$22.41735.44K
Sep 22, 2026$22.46$22.655$22.37$22.50954.28K
Sep 21, 2026$22.47$22.50$22.205$22.22707.32K
Sep 18, 2026$22.15$22.23$21.98$22.20818.57K
Sep 17, 2026$22.67$22.68$22.05$22.071.25M
Sep 16, 2026$22.94$23.10$22.86$22.97363.86K
Sep 15, 2026$22.89$23.005$22.77$22.96446.18K
Sep 14, 2026$22.77$22.895$22.67$22.86646.82K
Sep 11, 2026$22.49$22.54$22.25$22.35584.83K

Latest FMS news

The latest Smart Investors Daily articles mentioning FMS.

Stock researchCompany · Overview

FMS research

Overview

Company profile and research snapshot.

Company profile

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Hold
Average target
$17.85
Implied upside
—
Analysts
29
FMS recent ratings
DateFirmRatingTarget
Sep 21, 2026BERENBERGBuy—
Sep 4, 2026ODDO BHFBuy—
Aug 31, 2026BNP PARIBASUnderperform—
Aug 31, 2026INTESA SANPAOLO EQUITY RESEARCHBuy—
Aug 28, 2026METZLER EQUITIESHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 25, 2026

Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, today announced refinements to its China commercial strategy to support long-term growth and strengthen its market position through a more localized portfolio, increased commercialization of locally relevant innovation and a focused go-to-market approach.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By